JP2024507472A5 - - Google Patents

Info

Publication number
JP2024507472A5
JP2024507472A5 JP2023547485A JP2023547485A JP2024507472A5 JP 2024507472 A5 JP2024507472 A5 JP 2024507472A5 JP 2023547485 A JP2023547485 A JP 2023547485A JP 2023547485 A JP2023547485 A JP 2023547485A JP 2024507472 A5 JP2024507472 A5 JP 2024507472A5
Authority
JP
Japan
Prior art keywords
cells
induction medium
population
fgf
mesoderm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2023547485A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024507472A (ja
Filing date
Publication date
Priority claimed from GBGB2102297.5A external-priority patent/GB202102297D0/en
Application filed filed Critical
Publication of JP2024507472A publication Critical patent/JP2024507472A/ja
Publication of JP2024507472A5 publication Critical patent/JP2024507472A5/ja
Withdrawn legal-status Critical Current

Links

JP2023547485A 2021-02-18 2022-02-17 多能性幹細胞から造血性内皮細胞を生産する方法 Withdrawn JP2024507472A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2102297.5A GB202102297D0 (en) 2021-02-18 2021-02-18 Methods of Producing Haemogenic Endothelial Cells from Pluripotent Stem Cells
GB2102297.5 2021-02-18
PCT/EP2022/053985 WO2022175401A1 (en) 2021-02-18 2022-02-17 Methods of producing haemogenic endothelial cells from pluripotent stem cells

Publications (2)

Publication Number Publication Date
JP2024507472A JP2024507472A (ja) 2024-02-20
JP2024507472A5 true JP2024507472A5 (https=) 2025-02-25

Family

ID=75339190

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023547485A Withdrawn JP2024507472A (ja) 2021-02-18 2022-02-17 多能性幹細胞から造血性内皮細胞を生産する方法

Country Status (9)

Country Link
US (1) US20240124841A1 (https=)
EP (1) EP4294911A1 (https=)
JP (1) JP2024507472A (https=)
CN (1) CN116917465A (https=)
AU (1) AU2022223203A1 (https=)
CA (1) CA3208416A1 (https=)
GB (1) GB202102297D0 (https=)
IL (1) IL305018A (https=)
WO (1) WO2022175401A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201911958D0 (en) * 2019-08-20 2019-10-02 Adaptimmune Ltd Methods of t cell production
GB202205572D0 (en) 2022-04-14 2022-06-01 Adaptimmune Ltd Engineered T cells
CN115247152B (zh) * 2022-09-21 2022-12-27 呈诺再生医学科技(北京)有限公司 制备造血干细胞或造血干祖细胞的方法及培养长期再生造血干细胞的方法
CN118360247A (zh) * 2023-01-19 2024-07-19 中国科学院动物研究所 一种iSCLP细胞及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8652845B2 (en) * 2010-03-18 2014-02-18 Kyoto University Method for producing mesodermal cells by culturing under adherent conditions and without co-culture with cells from a different species in a serum-free medium
HUE043785T2 (hu) * 2013-03-13 2019-09-30 Wisconsin Alumni Res Found Módszerek és anyagok humán pluripotens õssejtek hematoendothelialis differenciálására meghatározott körülmények között
US10385313B2 (en) * 2013-10-01 2019-08-20 The Usa, As Represented By The Secretary, Department Of Health And Human Services Human IPSC-derived vascular-related and hematopoetic cells for therapies and toxicology/drug screenings
WO2015199127A1 (ja) * 2014-06-24 2015-12-30 国立大学法人京都大学 中胚葉細胞および造血細胞の製造方法
WO2016123100A1 (en) * 2015-01-26 2016-08-04 Fate Therapeutics, Inc. Methods and compositions for inducing hematopoietic cell differentiation
SG11201803145RA (en) * 2015-11-04 2018-05-30 Fate Therapeutics Inc Methods and compositions for inducing hematopoietic cell differentiation
CN112041428B (zh) * 2018-01-18 2024-05-24 新加坡科技研究局 用于在悬浮培养物中分化人多能干细胞系的方法
AU2019368313A1 (en) * 2018-10-24 2021-05-20 Hebecell Corporation Methods and systems for manufacturing hematopoietic lineage cells
GB201911957D0 (en) * 2019-08-20 2019-10-02 Adaptimmune Ltd Methods of producing haemogenic progenitor cells from pluripotent stem cells
EP4017969A1 (en) * 2019-08-20 2022-06-29 Adaptimmune Limited Culture medium for haematopoietic induction

Similar Documents

Publication Publication Date Title
JP2022545782A5 (https=)
JP2022545415A5 (https=)
JP2024507472A5 (https=)
US12606798B2 (en) Methods and materials for hematoendothelial differentiation of human pluripotent stem cells under defined conditions
JP7560502B2 (ja) 多能性幹細胞からｈｌａホモ接合免疫細胞への指向分化方法
JP2024100768A (ja) 血管コロニー形成細胞および非生着血管細胞
JP7061961B2 (ja) 多能性幹細胞の免疫細胞への分化を誘導する方法
JP6777620B2 (ja) 前原始線条及び中内胚葉細胞
Olivier et al. Large-scale production of embryonic red blood cells from human embryonic stem cells
JP6800859B2 (ja) 造血細胞分化を誘導するための方法および組成物
AU2013251785B2 (en) Method for developing natural killer cells from stem cells
JP2022545078A5 (https=)
JP2019136045A (ja) 造血前駆体の集団および造血前駆体のための幹細胞を富化する方法
CN114341349A (zh) 造血诱导培养基
US20220275332A1 (en) T cell production from rag inactivated ipscs
JP2013194049A (ja) ヒト造血幹細胞を増幅させるための組成物及び方法
IL305018A (en) Methods of producing haemogenic endothelial cells from pluripotent stem cells
CA2457296A1 (en) Methods for inducing differentiation of pluripotent cells
JP2023164892A (ja) 造血前駆細胞マーカー
CN101684454B (zh) 一种定型内胚层细胞的制备和分离方法
Lee et al. Forced expression of HoxB4 enhances hematopoietic differentiation by human embryonic stem cells
CN108642083A (zh) 一种将t细胞高效诱导成多能干细胞的重编程方法
CN115087732B (zh) 来自人T细胞来源的iPS细胞的细胞毒性T细胞
MX2007000318A (es) Metodos para identificar factores para diferencoar endodermo definitivo.
RU2022107099A (ru) Культуральная среда для гемопоэтической индукции